Abbott Laboratories (ABT) Return on Capital Employed (2009 - 2026)
Abbott Laboratories (ABT) posted Return on Capital Employed of 7.98% for Q2 2026, down 16.9% sequentially from 9.61% in Q1 2026, and down 286.0% YoY from 4.29% in Q2 2025.
Abbott Laboratories (ABT) Return on Capital Employed (2009 - 2026) Analysis & Trends
Abbott Laboratories has reported Return on Capital Employed for 18 years, with the latest figure at 7.98% in Q2 2026.
- Quarterly Return on Capital Employed fell 286.0% year-over-year to 7.98% in Q2 2026, while the trailing twelve-month figure through Jun 2026 was 7.98% (down 286.0% YoY) and the FY2025 annual result came in at 11.92%, up 111.0% from the prior year.
- Return on Capital Employed declined to 7.98% in Q2 2026 per ABT's latest filing, from 9.61% in the prior quarter.
- Over five years, Return on Capital Employed peaked at 26.41% in Q1 2022 and troughed at 7.98% in Q2 2026.
- A 5-year average of 13.47% and a median of 11.0% in 2023 frame the typical range for Return on Capital Employed.
- The sharpest annual moves came in 2022 and 2023: Return on Capital Employed surged 691 bps in 2022, then sank 1505 bps in 2023.
- Over 5 years, Return on Capital Employed stood at 26.07% in 2022, then sank by 58 bps to 11.01% in 2023, then decreased by 3 bps to 10.71% in 2024, then climbed by 9 bps to 11.68% in 2025, then tumbled by 32 bps to 7.98% in 2026.
- According to Business Quant data, Return on Capital Employed over the past three periods registered 7.98%, 9.61%, and 11.68% for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.49 Bn | 193.88 Bn | 7.27 Bn | 7.98% |
| 2 | Stryker | 127.80 Bn | 124.32 Bn | 4.50 Bn | 13.69% |
| 3 | Medtronic | 118.98 Bn | 109.76 Bn | 6.41 Bn | 8.02% |
| 4 | Boston Scientific | 73.58 Bn | 73.04 Bn | 3.85 Bn | 10.83% |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | 11.99% |
| 6 | Dexcom | 34.34 Bn | 32.39 Bn | 830.00 Mn | 27.21% |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.66 Bn | 2.18 Bn | 9.47% |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn | 12.84% |
| 9 | Steris | 23.07 Bn | 22.59 Bn | 684.20 Mn | 12.08% |
| 10 | Zimmer Biomet Holdings | 19.23 Bn | 18.82 Bn | 1.54 Bn | 6.10% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 7.98% |
| Mar 31, 2026 | 9.61% |
| Dec 31, 2025 | 11.68% |
| Sep 30, 2025 | 11.10% |
| Jun 30, 2025 | 10.85% |
| Mar 31, 2025 | 10.42% |
| Dec 31, 2024 | 10.71% |
| Sep 30, 2024 | 11.39% |
| Jun 30, 2024 | 10.99% |
| Mar 31, 2024 | 10.80% |
| Dec 31, 2023 | 11.01% |
| Sep 30, 2023 | 10.06% |
| Jun 30, 2023 | 10.34% |
| Mar 31, 2023 | 20.75% |
| Dec 31, 2022 | 26.07% |
| Sep 30, 2022 | 15.69% |
| Jun 30, 2022 | 16.55% |
| Mar 31, 2022 | 26.41% |
| Dec 31, 2021 | 24.51% |
| Sep 30, 2021 | 13.98% |